Laprophan Group, one of Morocco's leading pharmaceutical groups, has completed the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company generating annual revenues of approximately US$100m. Financial terms of Laprophan's first acquisition in Europe were not disclosed.
“This acquisition marks a new stage in our ambition to build an international pharmaceutical...
Muhammad Alhammad has been appointed as a director MENA Investments, and head of the Digital Health & Logistics Investments Unit at Public Investment Fund, Saudi Arabia's sovereign wealth fund. Alhammad brings over a decade of experience in the MENA region as a neurologist and healthcare consultant.